Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04531657 · ClinicalTrials.gov registry record
Influenza Vaccine in Lung Transplant Patients - Seroprotection
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 79
- Enrollment target
NCT04531657 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 79 participants.
The verdict
NCT04531657 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate two different definitions of influenza vaccine seroprotection at mid-season in lung transplant patients.
Interventions
- DRUG Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04531657
The ClinicalTrials.gov registry entry for NCT04531657 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Influenza vaccine is the first listed.
NCT04531657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04531657 about?
NCT04531657 is a clinical study titled "Influenza Vaccine in Lung Transplant Patients - Seroprotection". This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate two different definitions of inf...
What is the current status of trial NCT04531657?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2004-12. Estimated completion is 2009-07.
What interventions are being tested in trial NCT04531657?
The interventions under investigation include: Influenza vaccine (DRUG).
Who is sponsoring clinical trial NCT04531657?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.